Hospitech Respiration Overview
Hospitech Respiration is a medical-device company focused on the development and commercialization of airway management solutions. The company has developed a platform of solutions aimed at reducing complications related to prolonged mechanical ventilation. Hospitech Respiration has developed the AG100s Automatic Control Unit, a multipurpose airway-management system for automated control of the airway cuff pressure and automated evacuation of subglottic secretions; the AG ETT, a multi-lumen suction endotracheal tube; and the AG CUFFILL, a disposable digital manometer for airway cuff pressure monitoring and managing. The company's products are FDA, CE, and CFDA approved.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Hospitech Respiration expands footprint in China's medical market
Israeli MedTech company Hospitech Respiration has partnered with Chinese company AwakeZone to expand its footprint in China. The partnership will establish a wholly-owned subsidiary, Hospitech AwakeZone Medical, to lead production and commercialization of Hospitechs AnapnoGuard device in China. The device is designed to reduce complications in ventilated patients and works alongside ventilators. Hospitech Respiration aims to meet the increasing demand for its airway management devices in China and globally. The company sees China as the worlds second-largest medical device market and plans to work closely with local medical professionals and authorities. This partnership follows a similar deal Hospitech Respiration secured with Medline Industries Inc. in the US.
PartnersExpand
growth-positive
Hospitech Respiration announces partnership with Medline Industries for distributing its AG Cuffill device in the USA
Hospitech Respiration has partnered with Medline Industries for the distribution of the AG Cuffill device, a syringe-like manometer for airways cuff pressure management. Medline will be the exclusive distributor of the device in the United States healthcare markets. The partnership aims to expand the use of the AG Cuffill device and minimize cross-contamination, especially in Covid-19 patients. The partnership allows Hospitech to reach more healthcare and homecare providers across the USA. The AG Cuffill device helps monitor and adjust cuff pressure for intubated patients, reducing the risks and costs associated with improper cuff pressures. The partnership will leverage Medlines sales reps to expand the products presence in hospitals and surgery centers.
Partners
growth-positive
https://www.jpost.com/health-science/israeli-hospitals-using-brand-new-ventilator-to-fight-coronavirus-641169
Three major medical centers in Israel have adopted a new respiratory system called AnapoGuard, produced by Hospitech Respiration, an Israeli startup company. The system helps remove excess fluids in the lungs of coronavirus patients, reducing the risk of lung infections. The hospitals received the devices on a free loan-basis due to the shortage of ventilators. The system has already been in use at the Rambam Medical Center since 2018, and medical experts have welcomed its addition to their arsenal.
Customers
growth-positive
Major healthcare providers in Israel adopt new respiratory guard system amid second COVID-19 wave
Israeli medical device startup Hospitech Respiration has introduced the AnapnoGuard system, a respiratory guard system, to major hospitals in Israel to prevent ventilator-associated complications in COVID-19 patients. The system has been adopted by several hospitals, including the Sheba Medical Centre, Yitzhak Shamir Medical Centre, and Wolfson Medical Centre. AnapnoGuard consists of an automatic control unit and a proprietary multi lumen endotracheal tube, which reduce the likelihood of pulmonary infections and tracheal injury. The introduction of the system is a growth-positive development for Hospitech Respiration.
Customers
growth-positive
With intubated patients on the rise, Israeli innovation aims to prevent ventilator dangers
Israeli MedTech startup, Hospitech Respiration, has developed a respiratory guard system called AnapnoGuard that reduces complications caused by ventilator machines and minimizes exposure of medical staff to infected patients. The company has received FDA, CE, and CFDA approval and has found success with its products, including the AG Cuffill, due to the increase in COVID-19 patients. Hospitech Respiration is looking to expand its outreach in the U.S. to meet the demand for ventilated patients. The AnapnoGuard system and AG Cuffill are expected to become the standard of care in many hospitals.
CustomersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 1 |
| Investors | 1 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | www.hospitech.co.il |
Locations
Atir Yeda 15, Kfar Saba, Israel
Photos & Videos
4 item(s)
